- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 12 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.13: 3 residues within 4Å:- Chain A: Y.25, N.27, N.58
Ligand excluded by PLIPNAG.14: 3 residues within 4Å:- Chain A: N.277, E.278, N.279
Ligand excluded by PLIPNAG.15: 3 residues within 4Å:- Chain A: K.307, N.600, T.601
Ligand excluded by PLIPNAG.16: 4 residues within 4Å:- Chain A: N.613, Q.641
- Chain C: I.831, Q.833
Ligand excluded by PLIPNAG.17: 2 residues within 4Å:- Chain A: Y.652, N.654
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain A: N.706
- Chain C: Y.793
Ligand excluded by PLIPNAG.19: 4 residues within 4Å:- Chain A: A.703, E.1069, K.1070, N.1071
Ligand excluded by PLIPNAG.20: 2 residues within 4Å:- Chain A: N.328, Q.577
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain B: Y.25, N.27, N.58
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain B: N.277, E.278, N.279
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain B: K.307, N.600, T.601
Ligand excluded by PLIPNAG.24: 4 residues within 4Å:- Chain A: I.831, Q.833
- Chain B: N.613, Q.641
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain B: Y.652, N.654
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain A: Y.793
- Chain B: N.706
Ligand excluded by PLIPNAG.27: 4 residues within 4Å:- Chain B: A.703, E.1069, K.1070, N.1071
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain B: N.328, Q.577
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain C: Y.25, N.27, N.58
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain C: N.277, E.278, N.279
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain C: K.307, N.600, T.601
Ligand excluded by PLIPNAG.32: 4 residues within 4Å:- Chain B: I.831, Q.833
- Chain C: N.613, Q.641
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain C: Y.652, N.654
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain B: Y.793
- Chain C: N.706
Ligand excluded by PLIPNAG.35: 4 residues within 4Å:- Chain C: A.703, E.1069, K.1070, N.1071
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain C: N.328, Q.577
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Duyvesteyn, H.M.E. et al., Isolation of a pair of potent broadly neutralizing mAb binding to RBD and SD1 domains of SARS-CoV-2. Res Sq (2023)
- Release Date
- 2023-07-05
- Peptides
- Spike glycoprotein,Fibritin: ABC
BA.2-07 FAB HEAVY CHAIN: DFH
BA.2-07 FAB LIGHT CHAIN: EGI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DF
FH
HE
EG
GI
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 12 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Duyvesteyn, H.M.E. et al., Isolation of a pair of potent broadly neutralizing mAb binding to RBD and SD1 domains of SARS-CoV-2. Res Sq (2023)
- Release Date
- 2023-07-05
- Peptides
- Spike glycoprotein,Fibritin: ABC
BA.2-07 FAB HEAVY CHAIN: DFH
BA.2-07 FAB LIGHT CHAIN: EGI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DF
FH
HE
EG
GI
L